IDiyas

For the Inventor, By the Inventor

San Antonio, TX, United States of America

Gregory R Mundy

USPTO Granted Patents = 40 

Average Co-Inventor Count = 3.8

ph-index = 23

Forward Citations = 1,760(Granted Patents)


Location History:

  • San Antonio, WA (US) (2003)
  • San Antonio, TX (US) (1995 - 2012)

Company Filing History:

goldMedal24 out of 28 
 
Osteoscreen, Inc.
 patents
silverMedal13 out of 723 
 
Zymogenetics, Inc.
 patents
bronzeMedal4 out of 5,444 
 
University of Texas System
 patents
4. 3 out of 111 
 
Rhone-poulenc Rorer Pharmaceuticals Inc.
 patents
5. 3 out of 3 
 
Osteosa Inc.
 patents
6. 2 out of 9 
 
Xenotech, L.l.c.
 patents
7. 1 out of 662 
 
Dartmouth College
 patents
8. 1 out of 15,458 
 
University of California
 patents
9. 1 out of 1 
 
Osteosa Liquidation Trust
 patent
10. 1 out of 2 
 
Osteoscreen Ip, LLC
 patents
11. 4 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1995-2012

Loading Chart...
40 patents (USPTO):Explore Patents
1. 8299046 - Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth (2012-10-30),
2. 7618630 - Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists (2009-11-17),
3. 7211252 - Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists (2007-05-01),
4. 7101907 - Topical administration of statins for treatment of bone disorders (2006-09-05),
5. 6958220 - Inhibitors of proteasomal activity for stimulating hair growth (2005-10-25),
6. 6902721 - Inhibitors of proteasomal activity for stimulating bone growth (2005-06-07),
7. 6884769 - Inhibitors of proteasomal activity for stimulating hair growth (2005-04-26),
8. 6838436 - Inhibitors of proteasomal activity for stimulating bone growth (2005-01-04),
9. 6838252 - Inhibitors of proteasomal activity for stimulating hair growth (2005-01-04),
10. 6720344 - Methods and compositions for stimulating osteoblast proliferation or treating malignant cell proliferation and methods for selecting osteoblast proliferation stimulants (2004-04-13),
11. 6656904 - Inhibitors of proteasomal activity for stimulating bone and hair growth (2003-12-02),
12. 6649631 - Compositions and methods for treating bone deficit conditions (2003-11-18),
13. 6642216 - Isoprenoid pathway inhibitors for stimulating bone growth (2003-11-04),
14. 6492333 - Treatment of myeloma bone disease with proteasomal and NF-&kgr;B activity inhibitors (2002-12-10),
15. 6462019 - Inhibitors of proteasomal activity and production for stimulating bone growth (2002-10-08),

Title: Gregory R. Mundy: Innovator in Bone Growth Therapeutics

Introduction

Gregory R. Mundy, based in San Antonio, TX, has established himself as a prominent inventor in the field of biomedical innovation, particularly focusing on bone growth and health. With an impressive portfolio of 21 patents, Mundy has dedicated his career to developing solutions for bone deficit conditions.

Latest Patents

Among his notable contributions, some of the latest patents include:

1. Isoprenoid pathway inhibitors for stimulating bone growth.

2. Compositions and methods for treating bone deficit conditions.

These inventions highlight his commitment to advancing therapeutic options for individuals with bone health challenges.

Career Highlights

Mundy has had a significant impact through his work with various companies, including Zymogenetics, Inc. and Osteoscreen, Inc. His efforts in these organizations have been crucial in translating innovative ideas into practical applications that can benefit patients.

Collaborations

Throughout his career, Gregory R. Mundy has collaborated with esteemed colleagues such as Nand Baindur and Kirk G. Robbins. Their combined expertise has paved the way for groundbreaking advancements in the treatment of bone conditions.

Conclusion

With a track record of innovation and collaboration, Gregory R. Mundy continues to be a vital figure in the biomedical field. His work not only advances scientific understanding but also provides hope for effective treatments in bone health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…